Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Turning Point Therapeutics, Inc. (TPTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-05-21Dec-31-20Dec-05-20Dec-31-19Dec-31-18Dec-31-17
   10-K8-K10-K8-K10-K10-K10-K
Revenues  30.830.825.025.00.026.516.9
            Revenue growth  23.3%23.3%  -100.0%57.1% 
Cost of goods sold  0.0193.00.0113.40.00.00.0
Gross profit  30.8-162.225.0-88.40.026.516.9
            Gross margin  100.0%-526.0%100.0%-353.6% 100.0%100.0%
Selling, general and administrative   [+]268.875.9186.873.477.74.61.5
Research and development       21.115.2
Other operating expenses      -77.726.516.9
EBITDA   [+]     -25.5-16.7
            EBITDA margin  -772.0%-772.0%-647.3%-647.3% -96.3%-98.8%
Depreciation and amortization       0.10.1
EBIT   [+]-238.0-238.0-161.8-161.80.0-25.6-16.7
            EBIT margin  -772.0%-772.0%-647.3%-647.3% -96.8%-99.2%
Other income (expense), net   [+]1.41.44.54.5-72.10.90.1
Pre-tax income  -236.6-236.6-157.3-157.3-72.1-24.8-16.6
Income taxes  0.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -236.6-236.6-157.3-157.3-72.1-24.8-16.6
            Net margin  -767.3%-767.3%-629.2%-629.2% -93.5%-98.4%
   
Basic EPS   [+]($4.80)($4.80)($3.85)($3.85)($2.99)($7.31)($4.97)
Diluted EPS   [+]($4.80)($4.80)($3.85)($3.85)($2.99)($7.31)($4.97)
   
Shares outstanding (basic)   [+]49.349.340.840.824.13.43.3
Shares outstanding (diluted)   [+]49.349.340.840.824.13.43.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy